Saksenaea dorisiae sp. nov., a New Opportunistic Pathogenic Fungus from Europe

Table 3

In vitro antifungal susceptibility of Saksenaea dorisiae (BiMM-F232) towards 15 antifungal discs after 3 days of incubation at 37°C.

Antimycotic	Antifungal disc (concentration μg/disc)	Spores resistant/sensitive (mm zone)	Mycelial pellets resistant/sensitive (mm zone)
Amphotericin B	20	R/S (9)	R
Caspofungin	5	R	R
Ciclopirox	50	S (25)	R
Flucytosine	1	R	R
Griseofulvin	10	R	R
Nystatin	100 IU	R/S (6)	R
Terbinafine	30	S (25)	S (30)
Clotrimazole	50	S (25)	R
Econazole	10	S (15)	R
Fluconazole	100	R	R
Itraconazole	8	S (15)	R
Ketoconazole	15	R/S (8)	R
Miconazole	10	R/S (4)	R
Posaconazole	5	S (15)	R
Voriconazole	1	R	R

R = -resistant; S = sensitive. Responses with an asterisk indicate re-growing of the fungus into the inhibition zones after prolonged incubation (5 days at 37°C); spores (4.0 × 10⁵ CFU/mL) and mycelial pellets in size of 50–200 μm in diameter (2.0 × 10⁴/mL).